MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications (original) (raw)

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited disorder that is common in patients of Armenian ancestry. To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery. Renal amyloidosis, prevented by colchicine, is the most severe complication of FMF, a disorder associated with mutations in the MEFV gene. To evaluate the diagnostic and prognostic value of MEFV-gene analysis, we investigated 90 Armenian FMF patients from 77 unrelated families that were not selected through genetic-linkage analysis. Eight mutations, one of which (R408Q) is new, were found to account for 93% of the 163 independent FMF alleles, with both FMF alleles identified in 89% of the patients. In several instances, family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype. The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P=.0002 and P=.006, respectively). The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families.

Full Text

The Full Text of this article is available as a PDF (339.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksentijevich I., Torosyan Y., Samuels J., Centola M., Pras E., Chae J. J., Oddoux C., Wood G., Azzaro M. P., Palumbo G. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999 Apr;64(4):949–962. doi: 10.1086/302327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLUM A., GAFNI J., SOHAR E., SHIBOLET S., HELLER H. Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature. Ann Intern Med. 1962 Nov;57:795–799. doi: 10.7326/0003-4819-57-5-795. [DOI] [PubMed] [Google Scholar]
  3. Bernot A., da Silva C., Petit J. L., Cruaud C., Caloustian C., Castet V., Ahmed-Arab M., Dross C., Dupont M., Cattan D. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998 Aug;7(8):1317–1325. doi: 10.1093/hmg/7.8.1317. [DOI] [PubMed] [Google Scholar]
  4. Cotton R. G. Slowly but surely towards better scanning for mutations. Trends Genet. 1997 Feb;13(2):43–46. doi: 10.1016/s0168-9525(97)01011-1. [DOI] [PubMed] [Google Scholar]
  5. Dewalle M., Domingo C., Rozenbaum M., Ben-Chétrit E., Cattan D., Bernot A., Dross C., Dupont M., Notarnicola C., Levy M. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet. 1998 Jan;6(1):95–97. doi: 10.1038/sj.ejhg.5200170. [DOI] [PubMed] [Google Scholar]
  6. Dinarello C. A., Wolff S. M., Goldfinger S. E., Dale D. C., Alling D. W. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974 Oct 31;291(18):934–937. doi: 10.1056/NEJM197410312911804. [DOI] [PubMed] [Google Scholar]
  7. Eisenberg S., Aksentijevich I., Deng Z., Kastner D. L., Matzner Y. Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med. 1998 Oct 1;129(7):539–542. doi: 10.7326/0003-4819-129-7-199810010-00005. [DOI] [PubMed] [Google Scholar]
  8. Levy E. N., Shen Y., Kupelian A., Kruglyak L., Aksentijevich I., Pras E., Balow J. E., Jr, Linzer B., Chen X., Shelton D. A. Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246. Am J Hum Genet. 1996 Mar;58(3):523–534. [PMC free article] [PubMed] [Google Scholar]
  9. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., Migdal A., Padeh S., Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997 Oct;40(10):1879–1885. doi: 10.1002/art.1780401023. [DOI] [PubMed] [Google Scholar]
  10. Patarca R., Freeman G. J., Schwartz J., Singh R. P., Kong Q. T., Murphy E., Anderson Y., Sheng F. Y., Singh P., Johnson K. A. rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2733–2737. doi: 10.1073/pnas.85.8.2733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pras E., Aksentijevich I., Gruberg L., Balow J. E., Jr, Prosen L., Dean M., Steinberg A. D., Pras M., Kastner D. L. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med. 1992 Jun 4;326(23):1509–1513. doi: 10.1056/NEJM199206043262301. [DOI] [PubMed] [Google Scholar]
  12. Quaderi N. A., Schweiger S., Gaudenz K., Franco B., Rugarli E. I., Berger W., Feldman G. J., Volta M., Andolfi G., Gilgenkrantz S. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet. 1997 Nov;17(3):285–291. doi: 10.1038/ng1197-285. [DOI] [PubMed] [Google Scholar]
  13. Reddy B. A., Etkin L. D., Freemont P. S. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci. 1992 Sep;17(9):344–345. doi: 10.1016/0968-0004(92)90308-v. [DOI] [PubMed] [Google Scholar]
  14. Rogers D. B., Shohat M., Petersen G. M., Bickal J., Congleton J., Schwabe A. D., Rotter J. I. Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet. 1989 Oct;34(2):168–172. doi: 10.1002/ajmg.1320340206. [DOI] [PubMed] [Google Scholar]
  15. Saatçi U., Ozen S., Ozdemir S., Bakkaloglu A., Besbas N., Topaloglu R., Arslan S. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr. 1997 Aug;156(8):619–623. doi: 10.1007/s004310050677. [DOI] [PubMed] [Google Scholar]
  16. Samuels J., Aksentijevich I., Torosyan Y., Centola M., Deng Z., Sood R., Kastner D. L. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 1998 Jul;77(4):268–297. doi: 10.1097/00005792-199807000-00005. [DOI] [PubMed] [Google Scholar]
  17. Sohar E., Gafni J., Pras M., Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967 Aug;43(2):227–253. doi: 10.1016/0002-9343(67)90167-2. [DOI] [PubMed] [Google Scholar]
  18. Tissot C., Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem. 1995 Jun 23;270(25):14891–14898. doi: 10.1074/jbc.270.25.14891. [DOI] [PubMed] [Google Scholar]
  19. Yuval Y., Hemo-Zisser M., Zemer D., Sohar E., Pras M. Dominant inheritance in two families with familial Mediterranean fever (FMF). Am J Med Genet. 1995 Jul 3;57(3):455–457. doi: 10.1002/ajmg.1320570319. [DOI] [PubMed] [Google Scholar]
  20. Zemer D., Pras M., Sohar E., Modan M., Cabili S., Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986 Apr 17;314(16):1001–1005. doi: 10.1056/NEJM198604173141601. [DOI] [PubMed] [Google Scholar]
  21. Zemer D., Revach M., Pras M., Modan B., Schor S., Sohar E., Gafni J. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med. 1974 Oct 31;291(18):932–934. doi: 10.1056/NEJM197410312911803. [DOI] [PubMed] [Google Scholar]